Free Trial
→ $0. Later: $29.97. (From Profits Run) (Ad)tc pixel Free TLPPF Stock Alerts
OTCMKTS:TLPPF

Telix Pharmaceuticals (TLPPF) Stock Price, News & Analysis

Telix Pharmaceuticals logo
$9.43 0.00 (0.00%)
As of 11/12/2026
Compare

About Telix Pharmaceuticals Stock (OTCMKTS:TLPPF)

View Price History Chart DataSkip Price History Chart
Advanced
1 Day 5 Days 30 Days 90 Days 1 Year
Advanced

Key Stats

Today's Range
$9.43
▼
$9.43
50-Day Range
$8.75
▼
$12.55
52-Week Range
$5.91
▼
$13.00
Volume
50 shs
Average Volume
3,850 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.00
Consensus Rating
Buy

Company Overview

Telix Pharmaceuticals is an Australian biopharmaceutical company focused on developing and commercializing radiopharmaceuticals for cancer diagnosis and treatment. Its work combines radioactive isotopes with molecules designed to target specific tumor cells.

The company’s products and development programs include imaging agents for detecting and assessing cancer, as well as therapeutic candidates intended to deliver radiation to tumors. Its Illuccix product is used in prostate cancer imaging.

Telix conducts commercial and development activities in markets including Australia, North America and Europe. Its research programs span several cancers, including prostate, kidney and brain cancers.

AI Generated. May Contain Errors.

Receive TLPPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Telix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TLPPF Stock News Headlines

Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion
September 20, 2026  |  reuters.comhttps://www.reuters.com/legal/transactional/australias-telix-pharma-agrees-buy-germanys-itm-isotope-about-165-billion-2026-09-20/
Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals (OtherTLPPF) and Takeda Pharmaceutical Co (OtherTKPHF)
August 24, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/4001633/analysts-offer-insights-on-healthcare-companies-telix-pharmaceuticals-othertlppf-and-takeda-pharmaceutical-co-othertkphf/
Top Trader Reveals Stunning Black Friday Deal
Others paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.tc pixel
November 13 at 1:00 AM  |  Base Camp Trading (Ad)
Analysts Are Bullish on These Healthcare Stocks: Telix Pharmaceuticals (TLPPF), Impedimed Limited (IPDQF)
July 29, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/3539383/analysts-are-bullish-on-these-healthcare-stocks-telix-pharmaceuticals-tlppf-impedimed-limited-ipdqf/
J.P. Morgan Sticks to Its Buy Rating for Telix Pharmaceuticals (TLPPF)
July 25, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TLPPF/pressreleases/3447796/j-p-morgan-sticks-to-its-buy-rating-for-telix-pharmaceuticals-tlppf/
Analysts Conflicted on These Healthcare Names: Pyxis Oncology (PYXS) and Telix Pharmaceuticals (OtherTLPPF)
July 21, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/PYXS/pressreleases/3088243/analysts-conflicted-on-these-healthcare-names-pyxis-oncology-pyxs-and-telix-pharmaceuticals-othertlppf/
Bell Potter Sticks to Its Buy Rating for Telix Pharmaceuticals (TLPPF)
July 21, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/3394626/bell-potter-sticks-to-its-buy-rating-for-telix-pharmaceuticals-tlppf/
Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT) and Telix Pharmaceuticals (OtherTLPPF)
May 27, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TLPPF/pressreleases/2140159/analysts-offer-insights-on-healthcare-companies-summit-therapeutics-smmt-and-telix-pharmaceuticals-othertlppf/
See More Headlines

TLPPF Stock Analysis - Frequently Asked Questions

Telix Pharmaceuticals' stock was trading at $7.7361 on January 1st, 2026. Since then, TLPPF shares have increased by 21.9% and is now trading at $9.4325.

Shares of TLPPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Healthcare
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:TLPPF
CIK
2007191
Web
telixpharma.com
Phone
61-3-3093-3897
Fax
N/A
Employees
234
Year Founded
N/A

Price Target and Rating

Average Price Target for Telix Pharmaceuticals
$21.00
High Price Target
$22.00
Low Price Target
$20.00
Potential Upside/Downside
+122.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (OTCMKTS:TLPPF) was last updated on 11/12/2026 by MarketBeat.com Staff.
From Our Partners
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...
Base Camp Trading | Sponsoredtc pixel
Trump’s EO to send this $5 stock ripping higher…?
President Trump's December executive order declared space a national security and economic priority, fueling a...
Traders Agency | Sponsoredtc pixel
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...
Behind the Markets | Sponsoredtc pixel
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Uranium Mine Flood That Sparked a 2006 Price Surge Returns
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...
Digest Publishing | Sponsoredtc pixel
Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...
Weiss Ratings | Sponsoredtc pixel
A little-known law has been quietly applied to your savings for years.
Fox News reported that under current law, legal title to most stocks and bonds sits with a central institution...
Monetary Gold | Sponsoredtc pixel